Who are Plegisol In Plastic Container's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Saline solution isotonic 0.9% NaCl, Sodium Chloride 0.9% Intravenous Solution, Sodium Chloride, (24)NaCl 0,9%, fisiologic serum, Plasma-lyte, Plasma-lyte (static group).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/tpn-electrolytes-in-plastic-container.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Plegisol In Plastic Container — Competitive Intelligence Brief

Plegisol In Plastic Container (Calcium Chloride) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte replacement solution.

marketed Electrolyte replacement solution Electrolyte balance and fluid homeostasis Small molecule Live · refreshed every 30 min

Target snapshot

Plegisol In Plastic Container (Calcium Chloride) — Pfizer. Source of water and electrolytes regulating fluid balance, osmotic pressure, acid-base equilibrium, and neuromuscular function.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Plegisol In Plastic Container TARGET	Calcium Chloride	Pfizer	marketed	Electrolyte replacement solution	Electrolyte balance and fluid homeostasis	1971-01-01
Saline solution isotonic 0.9% NaCl	Saline solution isotonic 0.9% NaCl	Krankenhaus Barmherzige Schwestern Linz	marketed	Crystalloid fluid / Electrolyte replacement solution
Sodium Chloride 0.9% Intravenous Solution	Sodium Chloride 0.9% Intravenous Solution	Department of Medical Services Ministry of Public Health of Thailand	marketed	Electrolyte replacement solution
Sodium Chloride, (24)NaCl 0,9%	Sodium Chloride, (24)NaCl 0,9%	University of Oulu	marketed	Electrolyte replacement solution
fisiologic serum	fisiologic serum	Hospital Universitari Vall d'Hebron Research Institute	marketed	Electrolyte replacement solution
Plasma-lyte	Plasma-lyte	Fundación Santa Fe de Bogota	marketed	Crystalloid intravenous fluid / Electrolyte replacement solution
Plasma-lyte (static group)	Plasma-lyte (static group)	Algemeen Ziekenhuis Maria Middelares	marketed	Crystalloid intravenous fluid / Electrolyte replacement solution

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte replacement solution class)

Baxter Healthcare Corporation · 1 drug in this class
Centre Hospitalier Universitaire Dijon · 1 drug in this class
Centre Hospitalier Universitaire de Nice · 1 drug in this class
Department of Medical Services Ministry of Public Health of Thailand · 1 drug in this class
Federico II University · 1 drug in this class
Hospital Universitari Vall d'Hebron Research Institute · 1 drug in this class
Nepal Health Research Council · 1 drug in this class
Pfizer · 1 drug in this class
Shanghai Hengrui Pharmaceutical Co., Ltd. · 1 drug in this class
TC Erciyes University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Plegisol In Plastic Container — Competitive Intelligence Brief. https://druglandscape.com/ci/tpn-electrolytes-in-plastic-container. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab